loadpatents
Patent applications and USPTO patent grants for Wilson; Kevin J..The latest application filed is for "compositions useful for treating disorders related to kit".
Patent | Date |
---|---|
Inhibitors of RET Grant 11,279,688 - Brubaker , et al. March 22, 2 | 2022-03-22 |
Compositions Useful For Treating Disorders Related To Kit App 20210284645 - Hodous; Brian L. ;   et al. | 2021-09-16 |
Substituted pyrrolo[1,2-b]pyridazines for treating disorders related to KIT and PDGFR Grant 11,040,979 - Hodous , et al. June 22, 2 | 2021-06-22 |
Inhibitors Of Ret App 20200407341 - Brubaker; Jason D. ;   et al. | 2020-12-31 |
Compositions useful for treating disorders related to kit Grant 10,807,985 - Wilson October 20, 2 | 2020-10-20 |
Compounds that are ERK inhibitors Grant 10,759,805 - Lim , et al. Sep | 2020-09-01 |
Inhibitors of activin receptor-like kinase Grant 10,669,277 - Wilson , et al. | 2020-06-02 |
Inhibitors of RET Grant 10,584,114 - Brubaker , et al. | 2020-03-10 |
Inhibitors Of Activin Receptor-like Kinase App 20200031830 - Wilson; Kevin J. ;   et al. | 2020-01-30 |
Pyrrolo[1,2-b]pyridazine Compounds And Compositions Useful For Treating Disorders Related To Kit And Pdgfr App 20200024280 - Hodous; Brian L. ;   et al. | 2020-01-23 |
Inhibitors Of Ret App 20190185454 - BRUBAKER; Jason D. ;   et al. | 2019-06-20 |
Compositions Useful For Treating Disorders Related To Kit App 20190144454 - HODOUS; Brian L. ;   et al. | 2019-05-16 |
Compositions Useful For Treating Disorders Related To Kit And Pdgfr App 20190119280 - HODOUS; Brian L. ;   et al. | 2019-04-25 |
Inhibitors of activin receptor-like kinase Grant 10,233,186 - Brooijmans , et al. | 2019-03-19 |
Compounds useful for treating disorders related to RET Grant 10,227,329 - Brubaker , et al. | 2019-03-12 |
Inhibitors of RET Grant 10,183,928 - Kim , et al. Ja | 2019-01-22 |
Novel Compounds That Are Erk Inhibitors App 20180319804 - Lim; Jongwon ;   et al. | 2018-11-08 |
Compounds that are ERK inhibitors Grant 10,065,967 - Lim , et al. September 4, 2 | 2018-09-04 |
Inhibitors of RET Grant 10,030,005 - Brubaker , et al. July 24, 2 | 2018-07-24 |
Compositions useful for treating disorders related to kit and PDGFR Grant 10,000,496 - Hodous , et al. June 19, 2 | 2018-06-19 |
Compositions useful for treating disorders related to kit Grant 9,994,575 - Hodous , et al. June 12, 2 | 2018-06-12 |
Compositions useful for treating disorders related to kit Grant 9,944,651 - Hodous , et al. April 17, 2 | 2018-04-17 |
Compounds Useful For Treating Disorders Related To Ret App 20180022732 - BRUBAKER; JASON D. ;   et al. | 2018-01-25 |
Novel Compounds That Are Erk Inhibitors App 20170320882 - Lim; Jongwon ;   et al. | 2017-11-09 |
Inhibitors Of Activin Receptor-like Kinase App 20170298069 - Brooijmans; Natasja ;   et al. | 2017-10-19 |
Compounds that are ERK inhibitors Grant 9,745,307 - Lim , et al. August 29, 2 | 2017-08-29 |
Compositions Useful For Treating Disorders Related To Kit App 20170204104 - Hodous; Brian L. ;   et al. | 2017-07-20 |
Inhibitors Of Ret App 20170121312 - Brubaker; Jason D. ;   et al. | 2017-05-04 |
Compositions Useful For Treating Disorders Related To Kit And Pdfgr App 20170022206 - Hodous; Brian L. ;   et al. | 2017-01-26 |
Compositions Useful For Treating Disorders Related To Kit App 20160102097 - Hodous; Brian L. ;   et al. | 2016-04-14 |
Novel Compounds That Are Erk Inhibitors App 20160068532 - Lim; Jongwon ;   et al. | 2016-03-10 |
Compounds that are ERK inhibitors Grant 9,233,979 - Wilson , et al. January 12, 2 | 2016-01-12 |
Compounds that are ERK inhibitors Grant 9,226,922 - Wilson , et al. January 5, 2 | 2016-01-05 |
Compositions useful for treating disorders related to KIT Grant 9,200,002 - Hodous , et al. December 1, 2 | 2015-12-01 |
Novel Compounds That Are Erk Inhibitors App 20150266895 - Wilson; Kevin J. ;   et al. | 2015-09-24 |
Novel Compounds That Are Erk Inhibitors App 20150258074 - Wilson; Kevin J. ;   et al. | 2015-09-17 |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors Grant 9,096,559 - Harrington , et al. August 4, 2 | 2015-08-04 |
Compositions Useful For Treating Disorders Related To Kit App 20150111887 - Hodous; Brian L. ;   et al. | 2015-04-23 |
Heterocyclic compounds as ERK inhibitors Grant 8,999,957 - Deng , et al. April 7, 2 | 2015-04-07 |
4-carboxybenzylamino Derivatives As Histone Deacetylase Inhibitors App 20130137690 - Harrington; Paul ;   et al. | 2013-05-30 |
Novel Heterocyclic Compounds As Erk Inhbitors App 20130096084 - Deng; Yongqi ;   et al. | 2013-04-18 |
Phosphorus derivatives as histone deacetylase inhibitors Grant 7,981,874 - Close , et al. July 19, 2 | 2011-07-19 |
Silicon Derivatives As Histone Deacetylase Inhibitors App 20110130361 - Grimm; Jonathan ;   et al. | 2011-06-02 |
4-carboxybenzylamino Derivatives As Histone Deacetylase Inhibitors App 20100324046 - Harrington; Paul ;   et al. | 2010-12-23 |
Benzothiophene derivatives Grant 7,834,034 - Mampreian , et al. November 16, 2 | 2010-11-16 |
Phosphorus Derivatives As Histone Deacetylase Inhibitors App 20090270351 - Close; Joshua ;   et al. | 2009-10-29 |
Benzothiophene derivatives App 20090082308 - Hubbs; Jed Lee ;   et al. | 2009-03-26 |
Hydroxyalkylarylamide Derivatives App 20090062297 - Heidebrecht; Richard W. ;   et al. | 2009-03-05 |
Fluorinated Arylamide Derivatives App 20090012075 - Miller; Thomas A. ;   et al. | 2009-01-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.